Compare sustained-release pellet profiles across early, intermediate and late sampling points before qualifying an SR pellet supply offer.
R
Rraynex Editorial Team
2 min read
Overview
Procurement comparisons for sustained-release pharma pellets need a release curve, an agreed method and the identity of the material tested. An end point alone can hide an early increase or a slower middle segment. Have the formulation team specify which parts of the profile matter before evaluating supplier data.
Establish a common method record
Capture the apparatus, agitation, medium, sampling schedule, reporting units and specimen preparation. Record whether the data came from loose pellets, a capsule or a compressed multiparticulate tablet. Ask which batch and specification revision were used. Send both reports to the technical team if the methods differ.
Read early, middle and later results separately
Use early time points to identify unexpected release before the intended profile develops. Examine the middle part of the curve for differences that could matter to the formulation. Compare the later results to the target at the agreed time. Retain the spread of unit results where available. The average by itself can conceal variation relevant to qualification. EMA guidance on dissolution development and profile comparison
SR profile review worksheet
Finding
First follow-up
Earlier rise than expected
Check method, material and downstream handling before attributing the difference to the coating.
Similar final result with different intermediate data
Ask the lab to compare the full set of time points against the target profile.
Higher variation between units
Check sample preparation and the batch references. Define any confirmation testing.
Can I compare profiles generated at different agitation rates?
Record the difference and ask the laboratory how to establish a meaningful comparison under justified conditions. Treat the method as part of the data.
What if a supplier reports only the final time point?
Ask for the method, the earlier time points relevant to your formulation and the batch-specific results available for review.
Put insight into practice
Let’s discuss your next formulation project.
Share your product, strength, release requirements, expected quantity and destination market with our team.
Evaluate a pharma pellets manufacturer using a supplier qualification checklist for material identity, site scope, sample testing and commercial readiness.